Nomura
http://www.nomura.com/Nomura (NYSE: NMR) is a global investment banking and securities firm. The firm’s operations include Domestic Retail, Global Markets, Global Investment Banking, Global Merchant Banking, and Asset Management. Nomura is headquartered in Tokyo, Japan.
Nomura is represented in the Americas by Nomura Holding America (NHA). NHA’s major divisions are Fixed Income, Investment Banking, Equities and Asset Management.
View Older Stories View More Recent Stories
-
Welcome To Midgar - FINAL FANTASY VII REMAKE Available Now
-
Goldman Sachs Downgrades Nomura Holdings Inc. (8604:JP) (NMR) to Sell
-
Alphabet soup: How will post-virus economic recovery shape up?
-
Stitch Fix, Inc. (SFIX) Guidance Removal is Supply Side Driven - Nomura/Instinet
-
Apple (AAPL) PT Raised to $240 at Nomura/Instinet on Multiple Expansion
-
Form 6-K NOMURA HOLDINGS INC For: Apr 09
-
Coronavirus rout spurs China investors to dividend plays
-
Form 6-K NOMURA HOLDINGS INC For: Apr 08
-
NRI/IU Crypto-Asset Index Now Disseminated on QUICK
-
PJ SOLOMON Hires Andrew Fascia as Chief Financial Officer
-
PJ SOLOMON Hires Andrew Fascia as Chief Financial Officer
-
Kanazawa University Research: Atomic Force Microscopy Reveals High Heterogeneity in Bacterial Membrane Vesicles
-
Asian companies pose lower dividend risk due to stronger finances
-
BOK to keep rates unchanged this week but second-quarter easing possible: Reuters poll
-
Rush for masks, toilet paper slows Japan's household spending decline
-
Japan's Abe unveils 'massive' coronavirus stimulus worth 20% of GDP
-
Asian firms rush to meet $69 billion in second-quarter debt refinancing
-
Solid chip sales unlikely to cushion Samsung's virus-hit first quarter profit
-
China frees up $56 billion for virus-hit economy by slashing small banks' reserve requirements
-
Nomura/Instinet Upgrades Lam Research (LRCX) to Buy
-
Majesco (MJCO) Acquires InsPro Technologies
-
Majesco Acquires InsPro Technologies: Strengthens and Scales Position in L&A and Group Segment
-
China's factory activity seen recovering in March, but still in contraction after virus shock
-
China unexpectedly cuts reverse repo rate by most in five years to support virus-hit economy
-
Nomura/Instinet Upgrades Brilliance China Automotive Holdings Ltd. (1114:HK) (BCAUY) to Buy
-
Goldman, Morgan Stanley receive approvals for majority stakes in China ventures
-
UPDATE: Nomura/Instinet Upgrades Armstrong World Industries (AWI) to Buy
-
UPDATE: Nomura/Instinet Starts Corbus Pharmaceuticals (CRBP) at Buy
-
UPDATE: Nomura/Instinet Upgrades Gaming and Leisure (GLPI) to Buy, 'Are We Crazy?'
-
UPDATE: Nomura/Instinet Upgrades Square (SQ) to Neutral
-
Exelixis Announces Partner Takeda Receives Approval in Japan for CABOMETYX® (cabozantinib) Tablets for the Treatment of Curatively Unresectable or Metastatic Renal Cell Carcinoma
-
Best Buy (BBY) Cutting Buybacks Drives EPS 24% Below Consensus, PT to $60 at Nomura/Instinet
-
Thai cenbank may cut policy rate again as virus risks mount: Reuters poll
-
UPDATE: Nomura/Instinet Starts Maxim Integrated Products (MXIM) at Neutral
-
Bank of England ramps up bond-buying, cuts rates to near zero
-
Form 6-K NOMURA HOLDINGS INC For: Mar 19
-
ORCHID ISLAND CAPITAL ANNOUNCES MARCH 2020 MONTHLY DIVIDEND AND FEBRUARY 29, 2020 RMBS PORTFOLIO CHARACTERISTICS
-
Lam Research (LRCX) PT Lowered to $265 at Nomura/Instinet After the Company Revokes Guidance
-
UPDATE: Nomura/Instinet Starts Stitch Fix, Inc. (SFIX) at Buy
-
UPDATE: Nomura/Instinet Starts Revolve Group (RVLV) at Neutral
-
UPDATE: Nomura/Instinet Starts The RealReal Inc. (REAL) at Buy
-
Virus-hit Gulf has little room to boost revenue after oil price shock
-
MGM Resorts (MGM) Has Liquidity to Absorb 16 Month Closure - Nomura/Instinet
-
Near-zero U.S. rates may not sink the dollar
-
UPDATE: Nomura/Instinet Upgrades American Capital Agency (AGNC) to Buy
-
The plumbing behind world's financial markets is creaking. Loudly
-
How the longest bull run in history ended in pandemic panic
-
ULTA Salon (ULTA) PT Lowered to $225 at Nomura As Spending Environment Changes too Rapidly to Assess
-
Alnylam Pharmaceuticals (ALNY) Financing Need Increases Risk - Nomura/Instinet
-
Silver lining for some: virus shutdown boosts China non-life insurers

